The nephritogenic immune response

Margaret Fitzsimons, Mary H. Foster

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Recent insights into the etiopathogenesis of nephritogenic immune responses are derived primarily from experimental models of systemic and organ-specific autoimmunity. Genetic analyses and immune-related gene ablation studies indicate that multiple independent mechanisms determine disease susceptibility. However, full characterization of proximal immunologic events in many diseases awaits identification of the renal antigens recognized by nephritogenic lymphocytes. Advances in characterization of effector mechanisms include epitope mapping of several putative pathogenic glomerular antigens and identification of novel pathways of immune-mediated tissue injury, including those involved in glomerular- tubulointerstitial communication and tubulointerstitial fibrosis. Finally, successful interruption of signal transduction pathways and transforming growth factor-β1 blockade by gene therapy suggest novel approaches to therapeutic intervention in immunologic renal injury.

Original languageEnglish (US)
Pages (from-to)267-275
Number of pages9
JournalCurrent Opinion in Nephrology and Hypertension
Volume6
Issue number3
DOIs
StatePublished - Jan 1 1997

Fingerprint

Heymann Nephritis Antigenic Complex
Epitope Mapping
Kidney
Disease Susceptibility
Wounds and Injuries
Transforming Growth Factors
Autoimmunity
Genetic Therapy
Signal Transduction
Fibrosis
Theoretical Models
Lymphocytes
Antigens
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Nephrology

Cite this

@article{5b7602eacca84d1e8987a3ea6c6b0ec1,
title = "The nephritogenic immune response",
abstract = "Recent insights into the etiopathogenesis of nephritogenic immune responses are derived primarily from experimental models of systemic and organ-specific autoimmunity. Genetic analyses and immune-related gene ablation studies indicate that multiple independent mechanisms determine disease susceptibility. However, full characterization of proximal immunologic events in many diseases awaits identification of the renal antigens recognized by nephritogenic lymphocytes. Advances in characterization of effector mechanisms include epitope mapping of several putative pathogenic glomerular antigens and identification of novel pathways of immune-mediated tissue injury, including those involved in glomerular- tubulointerstitial communication and tubulointerstitial fibrosis. Finally, successful interruption of signal transduction pathways and transforming growth factor-β1 blockade by gene therapy suggest novel approaches to therapeutic intervention in immunologic renal injury.",
author = "Margaret Fitzsimons and Foster, {Mary H.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1097/00041552-199705000-00012",
language = "English (US)",
volume = "6",
pages = "267--275",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

The nephritogenic immune response. / Fitzsimons, Margaret; Foster, Mary H.

In: Current Opinion in Nephrology and Hypertension, Vol. 6, No. 3, 01.01.1997, p. 267-275.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The nephritogenic immune response

AU - Fitzsimons, Margaret

AU - Foster, Mary H.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Recent insights into the etiopathogenesis of nephritogenic immune responses are derived primarily from experimental models of systemic and organ-specific autoimmunity. Genetic analyses and immune-related gene ablation studies indicate that multiple independent mechanisms determine disease susceptibility. However, full characterization of proximal immunologic events in many diseases awaits identification of the renal antigens recognized by nephritogenic lymphocytes. Advances in characterization of effector mechanisms include epitope mapping of several putative pathogenic glomerular antigens and identification of novel pathways of immune-mediated tissue injury, including those involved in glomerular- tubulointerstitial communication and tubulointerstitial fibrosis. Finally, successful interruption of signal transduction pathways and transforming growth factor-β1 blockade by gene therapy suggest novel approaches to therapeutic intervention in immunologic renal injury.

AB - Recent insights into the etiopathogenesis of nephritogenic immune responses are derived primarily from experimental models of systemic and organ-specific autoimmunity. Genetic analyses and immune-related gene ablation studies indicate that multiple independent mechanisms determine disease susceptibility. However, full characterization of proximal immunologic events in many diseases awaits identification of the renal antigens recognized by nephritogenic lymphocytes. Advances in characterization of effector mechanisms include epitope mapping of several putative pathogenic glomerular antigens and identification of novel pathways of immune-mediated tissue injury, including those involved in glomerular- tubulointerstitial communication and tubulointerstitial fibrosis. Finally, successful interruption of signal transduction pathways and transforming growth factor-β1 blockade by gene therapy suggest novel approaches to therapeutic intervention in immunologic renal injury.

UR - http://www.scopus.com/inward/record.url?scp=0030762501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030762501&partnerID=8YFLogxK

U2 - 10.1097/00041552-199705000-00012

DO - 10.1097/00041552-199705000-00012

M3 - Article

C2 - 9263670

AN - SCOPUS:0030762501

VL - 6

SP - 267

EP - 275

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 3

ER -